TrialPath

TrialPath is an AI-powered, seven-step simulation that helps CROs, clinical operations, and logistics teams quickly evaluate whether an autologous cell or gene therapy shipment can move from collection site to manufacturer within your required viability window.

Unlike simple flight searches, TrialPath factors in real-world details that can derail advanced therapy shipments — like late-day apheresis times, limited flight schedules, ground courier timing, and manufacturer receiving hours. It’s designed for the high stakes of cell and gene therapy, where a single delayed shipment can threaten patient safety or trial timelines.

By entering your shipment’s locations and timing requirements, you’ll instantly get:

• Direct and backup flight options
• Ground transit estimates
• A color-coded logistics risk scorecard
• A clear Go/No-Go assessment
• A print-ready summary report

TrialPath delivers early, objective insights, well before your white-glove couriers conduct site-specific, detailed lane mapping. Use it to engage your logistics partners sooner or choose alternative sites before committing resources. No protocol-identifying information is requested, and no data you enter is stored or shared.

Outputs are for simulation and informational purposes only and are not intended as operational, clinical, or regulatory advice. REALM Bio and its parent company, Ministry of Science, Inc., disclaim all liability for any decisions or outcomes based on use of the TrialPath tool.